Chapter 2 How the Immune System Achieves Self-Nonself Discrimination During Adaptive Immunity

Advances in Immunology

Volumn 102, Issue , 2009, Pages 95-133

  Jiang, Hong ^a,b   Chess, Leonard ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 60; HLA E ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; CANCER IMMUNIZATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MELANOMA; MICROBIAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TUMOR IMMUNITY; ANIMAL; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNE SYSTEM; IMMUNITY; LYMPHOCYTE ACTIVATION; SELF TOLERANCE; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 66049120527     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/S0065-2776(09)01202-4     Document Type: Review

References (138)

1. Aldrich C.J., Waltrip R., Hermel E., Attaya M., Lindahl K.F., Monaco J.J., and Forman J. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter. J. Immunol. 149 (1992) 3773-3777
2. Aldrich C.J., DeClousc A., Woods A.S., Cotter R.J., Soloski M.J., and Forman J. Identification of a TAP-dependent header peptide recognized by alloreactive T cells specific for a Class 1-b antigen. Cell 79 (1994) 649-659
3. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., and Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science 298 (2002) 1395-1401
4. Anderson M.S., Venanzi E.S., Chen Z., Berzins S.P., Benoist C., and Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity 23 (2005) 227-239
5. Anderton S.M., and Wraith D.C. Selection and fine-tuning of the autoimmune T-cell repertoire. Nat. Rev. Immunol. 2 (2002) 487-498
6. Anderton S.M., Radu C.G., Lowrey P.A., Ward E.S., and Wraith D.C. Negative selection during the peripheral immune response to antigen. J. Exp. Med. 193 (2001) 1-11
7. Apostolou I., and von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199 (2004) 1401-1408
8. Apostolou I., Sarukhan A., Klein L., and von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3 (2002) 756-763
9. Asano M., Toda M., Sakaguchi N., and Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184 (1996) 387-396
10. Bacchetta R., Passerini L., Gambineri E., Dai M., Allan S.E., Perroni L., Dagna-Bricarelli F., Sartirana C., Matthes-Martin S., Lawitschka A., Azzari C., Ziegler S.F., et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116 (2006) 1713-1722
11. Bach J.F. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3 (2003) 189-198
12. Batchelor J.R., Lombardi G., and Lechler R.I. Speculations on the specificity of suppression. Immunol. Today 10 (1989) 37-40
13. Benoist C., and Mathis D. Autoimmunity provoked by infection: How good is the case for T cell epitope mimicry?. Nat. Immunol. 2 (2001) 797-801
14. Bevan M.J. In a radiation chimaera, host H-2 antigens determine immune responsiveness of donor cytotoxic cells. Nature 269 (1977) 417-418
15. Bevan M.J., and Fink P.J. The influence of thymus H-2 antigens on the specificity of maturing killer and helper cells. Immunol. Rev. 42 (1978) 3-19
16. Billingham R.E., Brent L., and Medawar P.B. Actively acquired tolerance of foreign cells. Nature 172 (1953) 603-606
17. Bluestone J.A., and Abbas A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3 (2003) 253-257
18. Bouneaud C., Kourilsky P., and Bousso P. Impact of negative selection on the T cell repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal deletion. Immunity 13 (2000) 829-840
19. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., and Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27 (2001) 68-73
20. Buhlmann J.E., Elkin S.K., and Sharpe A.H. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection. J. Immunol. 170 (2003) 5421-5428
21. Burnet M., and Fenner F. Production of Antibodies. 2nd edn (1949), McMillan, Melbourne
22. Cabaniols J.P., Cibotti R., Kourilsky P., Kosmatopoulos K., and Kanellopoulos J.M. Dose-dependent T cell tolerance to an immunodominant self peptide. Eur. J. Immunol. 24 (1994) 1743-1749
23. Chambers C.A., Cado D., Truong T., and Allison J.P. Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl. Acad. Sci. USA 94 (1997) 9296-9301
24. Chambers C.A., Kuhns M.S., Egen J.G., and Allison J.P. CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 19 (2001) 565-594
25. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
26. Chen Z., Benoist C., and Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc. Natl. Acad. Sci. USA 102 (2005) 14735-14740
27. Chen W., Zhang L., Liang B., Saenger Y., Li J., Chess L., and Jiang H. Perceiving the avidity of T cell activation can be translated into peripheral T cell regulation. Proc. Natl. Acad. Sci. USA 104 (2007) 20472-20477
28. Chidgey A., and Boyd R. Agonist peptide modulates T cell selection thresholds through qualitative and quantitative shifts in CD8 co-receptor expression. Int. Immunol. 9 (1997) 1527-1536
29. Christ M., McCartney-Francis N.L., Kulkarni A.B., Ward J.M., Mizel D.E., Mackall C.L., Gress R.E., Hines K.L., Tian H., Karlsson S., and Wah S.M. Immune dysregulation in TGF-beta 1-deficient mice. J. Immunol. 153 (1994) 1936-1946
30. Chun T., Aldrich C.J., Baldeon M.E., Kawczynski L.V., Soloski M.J., and Gaskins H.R. Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells. Immunology 94 (1998) 64-71
31. Cibotti R., Cabaniols J.P., Pannetier C., Delarbre C., Vergnon I., Kanellopoulos J.M., and Kourilsky P. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180 (1994) 861-872
32. + T-cell subsets: Regulation of differentiation and function. [Review] [14 refs]. Res. Immunol. 142 (1991) 7-9
33. Cohen I.R., Quintana F.J., and Mimran A. Tregs in T cell vaccination: Exploring the regulation of regulation. J. Clin. Invest. 114 (2004) 1227-1232
34. Cohn M. Whither T-suppressors: If they didn't exist would we have to invent them?. Cell. Immunol. 227 (2004) 81-92
35. Cohn M. What roles do regulatory T cells play in the control of the adaptive immune response?. Int. Immunol. 20 (2008) 1107-1118
36. Cook J.R., Wormstall E.M., Hornell T., Russell J., Connolly J.M., and Hansen T.H. Quantitation of the cell surface level of Ld resulting in positive versus negative selection of the 2C transgenic T cell receptor in vivo. Immunity 7 (1997) 233-241
37. Cotterill L.A., Stauss H.J., Millrain M.M., Pappin D.J., Rahman D., Canas B., Chandler P., Stackpoole A., Simpson E., Robinson P.J., and Dyson P.J. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide. Eur. J. Immunol. 27 (1997) 2123-2132
38. Davis M.M. The evolutionary and structural 'logic' of antigen receptor diversity. Semin. Immunol. 16 (2004) 239-243
39. Dorf M.E., and Benacerraf B. Suppressor cells and immunoregulation. Ann. Rev. Immunol. 2 (1984) 127-158
40. Durie F.H., Foy T.M., Masters S.R., Laman J.D., and Noelle R.J. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15 (1994) 406-411 [Review]
41. Fontenot J.D., and Rudensky A.Y. A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6 (2005) 331-337
42. + regulatory T cells. Nat. Immunol. 4 (2003) 330-336
43. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
44. Foy T.M., Page D.M., Waldschmidt T.J., Schoneveld A., Laman J.D., Masters S.R., Tygrett L., Ledbetter J.A., Aruffo A., Claassen E., Xu J.C., Flavell R.A., et al. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182 (1995) 1377-1388
45. Gammon G., and Sercarz E. Does the presence of self-reactive T cells indicate the breakdown of tolerance?. Clin. Immunol. Immunopathol. 56 (1990) 287-297
46. Garcia K.C., Degano M., Pease L.R., Huang M., Peterson P.A., Teyton L., and Wilson I.A. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279 (1998) 1166-1172
47. Goldrath A.W., and Bevan M.J. Selecting and maintaining a diverse T-cell repertoire. Nature 402 (1999) 255-262
48. Grossman Z., and Paul W.E. Autoreactivity, dynamic tuning and selectivity. Curr. Opin. Immunol. 13 (2001) 687-698
49. Grossman Z., Min B., Meier-Schellersheim M., and Paul W.E. Concomitant regulation of T-cell activation and homeostasis. Nat. Rev. Immunol. 4 (2004) 387-395
50. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
51. Hackett Jr. J., Stebbins C., Rogerson B., Davis M.M., and Storb U. Analysis of a T cell receptor gene as a target of the somatic hypermutation mechanism. J. Exp. Med. 176 (1992) 225-231
52. Han B., Serra P., Yamanouchi J., Amrani A., Elliott J.F., Dickie P., Dilorenzo T.P., and Santamaria P. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J. Clin. Invest. 115 (2005) 1879-1887
53. Hengartner H., Odermatt B., Schneider R., Schreyer M., Walle G., MacDonald H.R., and Zinkernagel R.M. Deletion of self-reactive T cells before entry into the thymus medulla. Nature 336 (1988) 388-390
54. Hernandez J., Ko A., and Sherman L.A. CTLA-4 blockade enhances the CTL responses to the p53 self-tumor antigen. J. Immunol. 166 (2001) 3908-3914
55. + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol. 32 (2002) 1282-1291
56. Hu D., Ikizawa K., Lu L., Sanchirico M.E., Shinohara M.L., and Cantor H. Analysis of regulatory CD8 T cells in mice deficient in the Qa-1 class 1b molecule, H2-T23. Nat. Immunol. 5 (2004) 516-523
57. Hurwitz A.A., Foster B.A., Kwon E.D., Truong T., Choi E.M., Greenberg N.M., Burg M.B., and Allison J.P. Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade. Cancer Res. 60 (2000) 2444-2448
58. Ignatowicz L., Kappler J., and Marrack P. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 84 (1996) 521-529
59. Imani F., and Soloski M.J. Heat shock proteins can regulate expression of the Tla region-encoded class 1b molecule Qa-1. Proc. Natl. Acad. Sci. USA 88 (1991) 10475-10479
60. Jaeckel E., Kretschmer K., Apostolou I., and von Boehmer H. Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunity. Semin. Immunol. 18 (2006) 89-92
61. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
62. Jerne N.K. The immune system: A web of V-domains. Harvey Lect. 70 (1974) 93-110
63. + T cells restricted by the MHC class IB molecule, QA-1. Annu. Rev. Immunol. 18 (2000) 185-216
64. Jiang H., and Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J. Clin. Invest. 114 (2004) 1198-1208
65. Jiang H., and Chess L. Regulation of immune responses by T cells. N. Engl. J. Med. 354 (2006) 1166-1176
66. + T cells and self-nonself discrimination: An essay on peripheral T-cell regulation. Hum. Immunol. 69 (2008) 721-727
67. + T cells in murine experimental allergic encephalomyelitis. Science 256 (1992) 1213-1215
68. + T cells expressing V beta 8 TCR: A role of the Qa-1 molecule. Immunity 2 (1995) 185-194
69. Jiang H., Kashleva H., Xu L.X., Forman J., Flaherty L., Pernis B., Braunstein N.S., and Chess L. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc. Natl. Acad. Sci. USA 95 (1998) 4533-4537
70. + T cells in EAE mice. Proc. Natl. Acad. Sci. USA 98 (2001) 6301-6306
71. + T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 100 (2003) 8378-8383 Epub 2003 Jun 24
72. Jiang H., Wu Y., Liang B., Zheng Z., Tang G., Kanellopoulos J., Soloski M., Winchester R., Goldstein I., and Chess L. An affinity/avidity model of peripheral T cell regulation. J. Clin. Invest. 115 (2005) 302-312
73. Jolly C.J., Wagner S.D., Rada C., Klix N., Milstein C., and Neuberger M.S. The targeting of somatic hypermutation. Semin. Immunol. 8 (1996) 159-168
74. Kappler J.W., Roehm N., and Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 49 (1987) 273-280
75. Kasprowicz D.J., Droin N., Soper D.M., Ramsdell F., Green D.R., and Ziegler S.F. Dynamic regulation of FoxP3 expression controls the balance between CD4(+) T cell activation and cell death. Eur. J. Immunol. 35 (2005) 3424-3432
76. Kawai K., and Ohashi P.S. Immunological function of a defined T-cell population tolerized to low-affinity self antigens. [published erratum appears in. Nature 374 (1995) 68-69
77. Kawai K., and Ohashi P.S. Immunological function of a defined T-cell population tolerized to low-affinity self antigens. [published erratum appears in. Nature 378 6555 (1995 Nov 23) 419
78. + T regulatory cells. Nat. Immunol. 4 (2003) 337-342
79. Kim J.M., Rasmussen J.P., and Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8 (2007) 191-197
80. Klaus S.J., Pinchuk L.M., Ochs H.D., Law C.L., Fanslow W.C., Armitage R.J., and Clark E.A. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152 (1994) 5643-5652
81. -/- mice. Science 256 (1992) 1210-1213
82. + T cells. J. Exp. Med. 173 (1991) 759-762
83. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6 (2005) 1219-1227
84. Kronenberg M., and Rudensky A. Regulation of immunity by self-reactive T cells. Nature 435 (2005) 598-604
85. Kurepa Z., Hasemann C.A., and Forman J. Qa-1b binds conserved class I leader peptides derived from several mammalian species. J. Exp. Med. 188 (1998) 973-978
86. Lenardo M., Chan K.M., Hornung F., McFarland H., Siegel R., Wang J., and Zheng L. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment [In Process Citation]. Annu. Rev. Immunol. 17 (1999) 221-253
87. Lenschow D.J., Walunas T.L., and Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14 (1996) 233-258
88. Levings M.K., and Roncarolo M.G. T-regulatory 1 cells: A novel subset of CD4 T cells with immunoregulatory properties. J. Allergy Clin. Immunol. 106 (2000) S109-S112
89. Liston A., Gray D.H., Lesage S., Fletcher A.L., Wilson J., Webster K.E., Scott H.S., Boyd R.L., Peltonen L., and Goodnow C.C. Gene dosage-limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J. Exp. Med. 200 (2004) 1015-1026
90. Litman G.W., Anderson M.K., and Rast J.P. Evolution of antigen binding receptors. Annu. Rev. Immunol. 17 (1999) 109-147
91. Lohse A.W., Mor F., Karin N., and Cohen I.R. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 244 (1989) 820-822
92. Lowen L.C., Aldrich C.J., and Forman J. Analysis of T cell receptors specific for recognition of class IB antigens. J. Immunol. 151 (1993) 6155-6165
93. Lu L., Ikizawa K., Hu D., Werneck M.B., Wucherpfennig K.W., and Cantor H. Regulation of activated CD4(+) T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26 (2007) 593-604
94. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12 (1994) 991-1045
95. Matzinger P. The danger model: A renewed sense of self science. Science 296 (2002) 301-305
96. Medzhitov R., and Janeway Jr. C. Innate immunity. N. Engl. J. Med. 343 (2000) 338-344
97. Medzhitov R., and Janeway Jr. C.A. Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298-300
98. Michaelsson J., Teixeira de Matos C., Achour A., Lanier L.L., Karre K., and Soderstrom K. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J. Exp. Med. 196 (2002) 1403-1414
99. Mittaz L., Rossier C., Heino M., Peterson P., Krohn K.J., Gos A., Morris M.A., Kudoh J., Shimizu N., Antonarakis S.E., and Scott H.S. Isolation and characterization of the mouse Aire gene. Biochem. Biophys. Res. Commun. 255 (1999) 483-490
100. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7 (1989) 145-173
101. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136 (1986) 2348-2357
102. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., Krohn K.J., Lalioti M.D., Mullis P.E., Antonarakis S.E., et al. Positional cloning of the APECED gene. Nat. Genet. 17 (1997) 393-398
103. Nossal G.J. Negative selection of lymphocytes. Cell 76 (1994) 229-239
104. Pardoll D. Does the immune system see tumors as foreign or self?. Annu. Rev. Immunol. 21 (2003) 807-839
105. Peterson D.A., DiPaolo R.J., Kanagawa O., and Unanue E.R. Quantitative analysis of the T cell repertoire that escapes negative selection. Immunity 11 (1999) 453-462
106. Pircher H., Rohrer U.H., Moskophidis D., Zinkernagel R.M., and Hengartner H. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature 351 (1991) 482-485
107. Rees W., Bender J., Teague T.K., Kedl R.M., Crawford F., Marrack P., and Kappler J. An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc. Natl. Acad. Sci. USA 96 (1999) 9781-9786
108. Roncarolo M.G., and Levings M.K. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12 (2000) 676-683
109. + regulatory T cells that express toll-like receptors. J. Exp. Med. 197 (2003) 397-401
110. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004) 531-562
111. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 (2005) 345-352
112. Sakaguchi S., Fukuma K., Kuribayashi K., and Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161 (1985) 72-87
113. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
114. Sandberg J.K., Franksson L., Sundback J., Michaelsson J., Petersson M., Achour A., Wallin R.P., Sherman N.E., Bergman T., Jornvall H., Hunt D.F., Kiessling R., and Karre K. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J. Immunol. 165 (2000) 25-33
115. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., and Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276 (2001) 37672-37679
116. Shevach E.M. Certified professionals: CD4(+)CD25(+) suppressor T cells. J. Exp. Med. 193 (2001) F41-F46
117. + suppressor T cells: More questions than answers. Nat. Rev. Immunol. 2 (2002) 389-400
118. Shevach E.M. From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity 25 (2006) 195-201
119. Slifka M.K., and Whitton J.L. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat. Immunol. 2 (2001) 711-717
120. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164 (2000) 183-190
121. van Elsas A., Hurwitz A.A., and Allison J.P. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J. Exp. Med. 190 (1999) 355-366
122. von Boehmer H., and Kisielow P. Self-nonself discrimination by T cells. Science 248 (1990) 1369-1373
123. von Boehmer H., Aifantis I., Gounari F., Azogui O., Haughn L., Apostolou I., Jaeckel E., Grassi F., and Klein L. Thymic selection revisited: How essential is it?. Immunol. Rev. 191 (2003) 62-78
124. + regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116 (2006) 2423-2433
125. Wagner S.D., and Neuberger M.S. Somatic hypermutation of immunoglobulin genes. Annu. Rev. Immunol. 14 (1996) 441-457
126. Waldmann H. The influence of the major histocompatibility complex on the function of T-helper cells in antibody formation. Immunol. Rev. 42 (1978) 202-223
127. + regulatory cells?. Immunity 14 (2001) 399-406
128. Wang R., Nelson A., Kimachi K., Grey H.M., and Farr A.G. The role of peptides in thymic positive selection of class II major histocompatibility complex-restricted T cells. Proc. Natl. Acad. Sci. USA 95 (1998) 3804-3809
129. Wang J., loan-Facsinay A., van der Voort E.I., Huizinga T.W., and Toes R.E. Transient expression of FOXP3 in human activated nonregulatory CD4(+) T cells. Eur. J. Immunol. 37 (2007) 129-138
130. Wood K.J., and Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3 (2003) 199-210
131. Wu Y., Zheng Z., Jiang Y., Chess L., and Jiang H. The specificity of T cell regulation that enables self-non-self discrimination in the periphery. Proc. Natl. Acad. Sci. USA 106 (2009) 534-539
132. Yagi J., and Janeway Jr. C.A. Ligand thresholds at different stages of T cell development. Int. Immunol. 2 (1990) 83-89
133. Zehn D., and Bevan M.J. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity 25 (2006) 261-270
134. Zhai Y., and Kupiec-Weglinski J.W. What is the role of regulatory T cells in transplantation tolerance?. Curr. Opin. Immunol. 11 (1999) 497-503
135. Zhao Z.S., Granucci F., Yeh L., Schaffer P.A., and Cantor H. Molecular mimicry by herpes simplex virus-type 1: Autoimmune disease after viral infection. Science 279 (1998) 1344-1347
136. Ziegler S.F. FOXP3: Not just for regulatory T cells anymore. Eur. J. Immunol. 37 (2007) 21-23
137. Zinkernagel R.M. Thymus and lymphohemopoietic cells: Their role in T cell maturation in selection of T cells' H-2-restriction-specificity and in H-2 linked Ir gene control. Immunol. Rev. 42 (1978) 224-270
138. Zuo T., Wang L., Morrison C., Chang X., Zhang H., Li W., Liu Y., Wang Y., Liu X., Chan M.W., Liu J.Q., Love R., et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 129 (2007) 1275-1286